Press Release
Dr. Russell Richmond Joins PeraHealth Board of Directors

Healthcare entrepreneur and physician joins the board of predictive, real-time clinical surveillance company

CHARLOTTE, N.C. – February 20, 2017 – PeraHealth, a provider of predictive, real-time clinical surveillance solutions, announces the appointment of Russell Richmond, M.D. to its board of directors. Dr. Richmond, a physician and entrepreneur focused on improving the quality, safety, and value of healthcare delivery, is currently the chief executive officer of Advanced Practice Strategies (APS).

“The combination of PeraHealth’s unique founding purpose and its innovative technology puts the company in the perfect position to make improvements in patient care and quality,” said Dr. Richmond. “PeraHealth is leveraging predictive analytics to identify at-risk patients sooner for earlier intervention, and I look forward to supporting the PeraHealth team continue to make an impact in healthcare.”

After the death of their mother, it became clear to PeraHealth founders Michael and Steven Rothman that while the data was essentially stored in the EHR, it was not synthesized into meaningful information to actively help clinicians in situations like their mother’s, whose deterioration was unrecognized. By leveraging the Rothman Index, a validated patient acuity score, PeraHealth software solutions enable healthcare providers to identify at-risk patients, helping to improve outcomes and reduce costs.

“Russ’ industry knowledge and experience growing healthcare companies will be invaluable,” says Stephanie Alexander, CEO of PeraHealth. “We are excited to have Russ join the PeraHealth team and look forward to having his unique combination of clinical, technical and strategic experience augment our board’s expertise.”

PeraHealth solutions are in use by more than 80 leading hospitals and care providers and help determine when to discharge patients; prioritize patient bedside visits and nursing assignments; improve documentation accuracy and timeliness; optimize ICU bed use; and identify opportunities for palliative care consults. Customers include Yale New Haven Health System, Houston Methodist, Children’s Hospital of Philadelphia, Memorial Sloan Kettering Cancer Center, and Mission Health. PeraHealth products are integrated with all major EHR vendors, enabling care providers to monitor patients at the unit, hospital and system-level.

About Dr. Russ Richmond: • CEO of Advanced Practice Strategies (Current) • Executive Chairman and Board Director for Validic (Current) • CEO of Objective Health (2010-2013) • Executive Vice President of Verisk Health (2006-2009) • McKinsey & Company consultant (1999-2005; 2009-2010) • Internal Medicine and Pediatrics internship at the University of Michigan • M.D from the University of Cincinnati, and a B.S in Biology from the University of Michigan.

About PeraHealth

PeraHealth is transforming healthcare through the intelligent use of data. By leveraging the Rothman Index, a validated patient acuity score, PeraHealth’s clinical surveillance software solutions enable healthcare providers to identify at-risk patients sooner for earlier intervention. More than 80 leading hospitals and care providers, such as Yale New Haven Health System, Houston Methodist, Children’s Hospital of Philadelphia and Memorial Sloan Kettering Cancer Center, utilize PeraHealth’s real-time, predictive analytics to improve quality and reduce costs. For more information, visit PeraHealth.com and @PeraHealth.com